These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
411 related articles for article (PubMed ID: 24926685)
1. Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect. Yan F; Wang Q; Xu C; Cao M; Zhou X; Wang T; Yu C; Jing F; Chen W; Gao L; Zhao J PLoS One; 2014; 9(6):e99245. PubMed ID: 24926685 [TBL] [Abstract][Full Text] [Related]
2. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity. Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220 [TBL] [Abstract][Full Text] [Related]
3. The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells. Yoon S; Kim J; Lee H; Lee H; Lim J; Yang H; Shin SS; Yoon M J Ethnopharmacol; 2017 Jan; 195():204-213. PubMed ID: 27845265 [TBL] [Abstract][Full Text] [Related]
4. Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1. Ziamajidi N; Khaghani S; Hassanzadeh G; Vardasbi S; Ahmadian S; Nowrouzi A; Ghaffari SM; Abdirad A Food Chem Toxicol; 2013 Aug; 58():198-209. PubMed ID: 23603006 [TBL] [Abstract][Full Text] [Related]
5. Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes. Kang OH; Kim SB; Mun SH; Seo YS; Hwang HC; Lee YM; Lee HS; Kang DG; Kwon DY Int J Mol Med; 2015 Mar; 35(3):803-9. PubMed ID: 25605057 [TBL] [Abstract][Full Text] [Related]
6. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα). Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610 [TBL] [Abstract][Full Text] [Related]
7. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells. Zeng L; Tang W; Yin J; Feng L; Li Y; Yao X; Zhou B Cell Physiol Biochem; 2016; 40(3-4):453-464. PubMed ID: 27889747 [TBL] [Abstract][Full Text] [Related]
11. cAMP response element binding protein H mediates fenofibrate-induced suppression of hepatic lipogenesis. Min AK; Jeong JY; Go Y; Choi YK; Kim YD; Lee IK; Park KG Diabetologia; 2013 Feb; 56(2):412-22. PubMed ID: 23150180 [TBL] [Abstract][Full Text] [Related]
12. Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD. Montagner A; Polizzi A; Fouché E; Ducheix S; Lippi Y; Lasserre F; Barquissau V; Régnier M; Lukowicz C; Benhamed F; Iroz A; Bertrand-Michel J; Al Saati T; Cano P; Mselli-Lakhal L; Mithieux G; Rajas F; Lagarrigue S; Pineau T; Loiseau N; Postic C; Langin D; Wahli W; Guillou H Gut; 2016 Jul; 65(7):1202-14. PubMed ID: 26838599 [TBL] [Abstract][Full Text] [Related]
13. Fish oil and fenofibrate prevented phosphorylation-dependent hepatic sortilin 1 degradation in Western diet-fed mice. Li J; Bi L; Hulke M; Li T J Biol Chem; 2014 Aug; 289(32):22437-49. PubMed ID: 24986865 [TBL] [Abstract][Full Text] [Related]
14. Activation of peroxisome proliferator-activated receptor-alpha in mice induces expression of the hepatic low-density lipoprotein receptor. Huang Z; Zhou X; Nicholson AC; Gotto AM; Hajjar DP; Han J Br J Pharmacol; 2008 Oct; 155(4):596-605. PubMed ID: 18852694 [TBL] [Abstract][Full Text] [Related]
15. Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice. López-Oliva ME; Garcimartin A; Muñoz-Martínez E Br J Nutr; 2017 Dec; 118(11):914-929. PubMed ID: 29173234 [TBL] [Abstract][Full Text] [Related]
16. Bezafibrate at clinically relevant doses decreases serum/liver triglycerides via down-regulation of sterol regulatory element-binding protein-1c in mice: a novel peroxisome proliferator-activated receptor alpha-independent mechanism. Nakajima T; Tanaka N; Kanbe H; Hara A; Kamijo Y; Zhang X; Gonzalez FJ; Aoyama T Mol Pharmacol; 2009 Apr; 75(4):782-92. PubMed ID: 19124612 [TBL] [Abstract][Full Text] [Related]